Products containing cannabinoids such as cannabidiol (CBD) have proliferated since 2018, when the Agriculture Improvement Act removed hemp (ie, cannabis containing <0.3% Δ9-tetrahydrocannabinol [THC]) from the US controlled substances list. Topical cannabinoid products can be purchased nationwide at retail stores and over the internet, yet research on these products is scarce. The objective of this study is to evaluate the cannabinoid content (ie, CBD and THC) and label accuracy of topical cannabinoid products and to quantify their therapeutic and nontherapeutic claims.
You can read the full study published by the Jama Network here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794440?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072022
For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.
Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.